KORU Medical Systems, Inc.

KRMD Healthcare Medical Instruments & Supplies

KORU Medical Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $41.1 million, up 22.2% from fiscal 2024. In the quarter to June 2026, revenue grew 18.2%, EPS grew 222.2%, free cash flow grew 26.2% and total debt fell 50.9%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

3.00 0.03 −0.99%
Market cap
$139.9M
P/E
0.0×
Fwd P/E
−89.3×
Dividend yield
—
F-score
5/9
Altman Z
14.46
Beneish M
−2.90
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
4.53 6.52 4.63 4.29
P/FCF ratio
0.00 0.00 1,645.82 775.14
P/Operating CF
2,707.87 245.11 13,625.60 895.66
P/B ratio
10.76 15.74 11.84 10.72
EV/Sales
4.32 6.31 4.43 4.11
EV/EBITDA
0.00 0.00 0.00 0.00
EV/FCF
(992.05) (532.53) 1,574.16 742.24
Current Ratio
2.48 2.44 2.33 2.72
Net Debt/EBITDA
12.59 23.90 13.07 (9.82)
Debt/Equity
0.01 0.00 0.00 0.00
Earnings Yield
(2.21%) (1.11%) (1.26%) (1.06%)
Free Cash Flow Yield
(0.10%) (0.18%) 0.06% 0.13%
Free Cash Flow per Share
0.00 0.01 0.00 (0.01)
Book value per Share
0.36 0.37 0.37 0.39
Free Cash Flow
0.01 0.67 (0.08) (0.36)
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates